Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Zystische Fibrose
10. Juni 2026
Suchen
medline.ch
Zystische Fibrose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 999
Artikel 1 - 20 / 19974
Unravelling the developmental origins of cystic fibrosis-related diabetes.
Diabetologia
Cho A, Nostro MC.
PMID: 42262528 [PubMed - as supplied by publisher]
Melatonin to Induce Natural Sleep During Multiple-Breath Washout in Infants and Toddlers With Cystic Fibrosis.
Pediatr Pulmonol
Jouret N, Verhulst S, Van Hoorenbeeck K.
PMID: 42252928 [PubMed - indexed for MEDLINE]
CT ASSESSMENT OF BODY COMPOSITION AND LUNG EVOLUTION IN CYSTIC FIBROSIS AFTER ELEXACAFTOR-TEZACAFTOR-IVACAFTOR: A COHORT STUDY.
Respir Med
Soria-Utrilla V, Piñar-Gutiérrez A, Sánchez-Torralvo FJ, Adarve-Castro A, Padial M, Jiménez-Sánchez A, Quintana-Gallego ME, Olveira C, Girón MV, Olveira G, García-Luna PP.
PMID: 42251917 [PubMed - as supplied by publisher]
A multi-center study of non-invasive colorectal cancer evaluation in cystic fibrosis (NICE-CF).
J Cyst Fibros
Hachem C, Tressel W, Hinckley Stukovsky KD, Joyeux CN, Schwarzenberg SJ, Freedman SD.
PMID: 42248729 [PubMed - as supplied by publisher]
Bone Disease in Non-Cystic Fibrosis Bronchiectasis: Connections, Mechanisms, and Care Gaps.
Chest
Doumat G, Haroon S, Maalouf NM, Jain R.
PMID: 42242549 [PubMed - as supplied by publisher]
Predicting clinical efficacy of lung gene delivery in people with cystic fibrosis: which in vitro and in vivo models best predict outcomes in human lungs?
Expert Opin Drug Deliv
Munir M, Wiyana J, Werder RB, Butcher NJ, Burow R, McCarron A, Yu Q, Waters SA, Kaminskas LM.
PMID: 42240557 [PubMed - as supplied by publisher]
Radiologic progression with minimal functional decline in cystic fibrosis: Insights from a prospective study.
World J Radiol
Suhail JM, Wagay MI, Parry AH, Bhat IM, Sheikh RR, Bhat MA.
PMID: 42238223 [PubMed]
Early effect of CFTR modulators on the mental health of patients with cystic fibrosis and parents.
Eur J Pediatr
Yeti, Akyan Soyda, Özkan Tabakç, Bilgiç I, Kürtül Çakar M, Akca Dinç G, Ünlü A, Y, Çetin MA, Tu, Ademhan Tural D, Ery, , Çöp E, Cinel G.
PMID: 42234158 [PubMed - indexed for MEDLINE]
Maldigestion, dysbiosis, inflammation and dysmotility: a toxic tetrad in the CF gut.
J Cyst Fibros
Bass R, Smyth AR.
PMID: 42223231 [PubMed - indexed for MEDLINE]
The Diagnostic Complexities of Cystic Fibrosis: When to Think of It and What to Do?
Br J Hosp Med (Lond)
Weitnauer L, Simmonds NJ.
PMID: 42216598 [PubMed - indexed for MEDLINE]
Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosis.
Pediatr Pulmonol
Famulska P, Wi, Naro, Sapiejka E, Osi, Musia, Szczepankiewicz A, T, Wiesner A, Steinert-Dymecki A, Jó, Wojsyk-Banaszak I.
PMID: 42206906 [PubMed - indexed for MEDLINE]
Three-year outcomes of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A real-world study.
Med Clin (Barc)
Zamarrón de Lucas E, Crespo Catalán C, Romero Campos B, Sanz Sanjosé B, Longás Ouzzine M, Aponte Guevara CS, Álvarez-Sala Walther R, Prados Sánchez MC.
PMID: 42202689 [PubMed - as supplied by publisher]
Efficacy and safety of the cystic fibrosis transmembrane conductance regulator inhibitor GLPG2737 for autosomal dominant polycystic kidney disease: phase 2a MANGROVE study.
Nephrol Dial Transplant
Gansevoort RT, Hueso M, Pisani A, Van den Bergh D, Muller K, Lazaryan A, Fieuw AM, Su.
PMID: 42201338 [PubMed - as supplied by publisher]
Host-Pathogen Interactions in Cystic Fibrosis Lung Disease: Adaptation, Persistence, and Clinical Implications of Pseudomonas aeruginosa.
Pathogens
Capraz Yavuz B.
PMID: 42198683 [PubMed - indexed for MEDLINE]
Mental Health in Cystic Fibrosis in the Modulator Era: Epidemiology, Prognostic Significance, and Therapeutic Implications.
J Clin Med
Almulhem MM, Siraj RA.
PMID: 42194913 [PubMed]
Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective (part 2: special situations/respiratory complications).
Respir Med
Fayon M, Hill K, Riberi L, Dournes G, Burgel PR, Messore B, Waldron M, Svedberg M, Lammertyn E, Fustik S, Gramegna A, Stahl M, Kerpel-Fronius A, Balbi M, Ciet P, Chassagnon G, Ferrero C, Sutharsan S, Opitz M, Andrinopoulou ER, Maher M, Duckers J, Tiddens H, Sermet-Gaudelus I.
PMID: 42190839 [PubMed - in process]
Telehealth by Home Monitoring and Video Consultation for Children With Cystic Fibrosis: Qualitative and Quantitative Study.
JMIR Form Res
Jørgensen MN, Nielsen KG, Aalling M, Traustadottir R, Hansson H.
PMID: 42189648 [PubMed - indexed for MEDLINE]
A critical analysis on ENaC inhibitors, unravelling molecular medicinal insights and promising research roadmap in the treatment of cystic fibrosis.
Eur J Med Chem
Lo Mascolo F, Lipani A, Giuffrida S, Barreca M, Bivacqua R, Spanò V, Raimondi MV, Montalbano A, Borrelli A, Venturini A, Guidone D, Genovese M, Galietta LJV, Barraja P.
PMID: 42184559 [PubMed - indexed for MEDLINE]
Health disparities in cystic fibrosis in the context of the exposome: recent developments and future directions.
Expert Rev Respir Med
Oates GR, Stephens C, Schechter MS.
PMID: 42176249 [PubMed - as supplied by publisher]
Real-life effectiveness and safety of lumacaftor/ivacaftor in preschool children with cystic fibrosis: data from an italian multicentre study.
Pediatr Res
Presti S, Cimbalo C, Terminiello A, Fevola C, Daccò V, Sepe A, Troiani P, Casciaro R, Di Dio N, Castellani C, Esposito I, Ficili F, De Venuto D, Calderazzo MA, Ripani P, Salvatore D, Terlizzi V.
PMID: 42174207 [PubMed - as supplied by publisher]
Artikel 1 - 20 / 19974
Seite 1 von 999
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung